Edwards Lifesciences | EW - Ebitda



金融业
股票价格
USD
资产
USD 13.32B
现金及等价物
USD 2.4B
销售成本
USD 362.6M
流动资产
USD 6.23B
流动负债
USD 1.41B
债务
USD 600M
EBIT
USD 514.7M
EBITDA
USD 70.1M
员工
15.8K
EPS每股收益
USD 0.78
股本和储备
USD 10.33B
销售毛利
USD 1.29B
债务利息支出
USD 35.9M
利息收入
USD 56.3M
贷款资金
USD 600M
市值
USD 51.22B
净收入
USD 380.7M
营业费用
USD 1.13B
营业利润
USD 514.7M
普通股股本
USD 580.7M
PE价格收益
26.87
税前利润
USD 348.4M
销售收入
USD 1.65B
销售和管理费用
USD 522.2M
股票
USD 1.12B
贸易债权人
USD 181.1M
应收帐款人
USD 912.1M


Ebitda 更改 日
Abbott USD 3.27B 178M 2025-12
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 17.07M 2.79M 2026-03
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
ICU Medical USD 98.68M 489K 2026-03
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Masimo USD 85.5M 6.4M 2026-03
Medtronic USD 2.81B 119M 2026-03
Merit Medical Systems USD 97.23M 17.69M 2025-12
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 247.07M 575.88M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12